TR4 | Jotup

CGIAR/Alliance of Bioversity Int'l & CIAT and Boost Biomes announce a project to evaluate biological treatment for critical diseases of bananas

Retrieved on:

Wednesday, July 26, 2023

BERKELEY, Calif. and ROME, July 26, 2023 /PRNewswire/ -- CGIAR research center Alliance of Bioversity International and CIAT ("Alliance/CGIAR"), and Boost Biomes, Inc. ("Boost") announced today the initiation of a project to evaluate Boost's biological products to address Fusarium wilt in bananas.

Key Points:

BERKELEY, Calif. and ROME, July 26, 2023 /PRNewswire/ -- CGIAR research center Alliance of Bioversity International and CIAT ("Alliance/CGIAR"), and Boost Biomes, Inc. ("Boost") announced today the initiation of a project to evaluate Boost's biological products to address Fusarium wilt in bananas.
Alliance solutions address the global crises of malnutrition, climate change, biodiversity loss, and environmental degradation.
Their joint program will address diseases in bananas for which there is currently no effective treatment, and where biological products are preferred, starting with Fusarium wilt Tropical Race 4.
We look forward to working with the Alliance/CGIAR on this first product, and advanced products generated via our platform technology."

Fexa Announces Trakref TR4: Revolutionizing the HVAC/R Compliance Industry with Enhanced Speed, Improved Workflows, and Modern Navigation

Retrieved on:

Tuesday, May 23, 2023

Software as a service, Learning curve, Overalls, Built environment, HVAC, Acquisition, Engineering, TR4, Asset management, Online shopping, Tom Fexas

MULLICA HILL, N.J., May 23, 2023 /PRNewswire-PRWeb/ -- Trakref, (A Fexa Solution) a leading provider of refrigerant compliance and sustainability solutions, is excited to announce the launch of TR4, the next generation of its groundbreaking software platform. After four years of meticulous research, development, and collaboration, TR4 is set to redefine the industry standard for asset management systems.

Key Points:

Fexa Announces Trakref TR4: Revolutionizing the HVAC/R Compliance Industry with Enhanced Speed, Improved Workflows, and Modern Navigation
MULLICA HILL, N.J., May 23, 2023 /PRNewswire-PRWeb/ -- Trakref, (A Fexa Solution) a leading provider of refrigerant compliance and sustainability solutions, is excited to announce the launch of TR4, the next generation of its groundbreaking software platform.
After four years of meticulous research, development, and collaboration, TR4 is set to redefine the industry standard for asset management systems.
"We listened to our Trakref customers and partners, conducted in-depth interviews, and made the necessary engineering advancements to ensure TR4 is the ultimate solution for refrigerant compliance and sustainability management solutions," said Ted Atwood, chief compliance and sustainability officer at Fexa.
"Fexa continues its mission to help facilities and operations teams leverage technology to drive better business outcomes," said Kurt Smith, CEO of Fexa.

MustGrow Reports 100% Control of Banana Disease at Economic Rates; Advancing to Field Trials in Colombia

Retrieved on:

Tuesday, February 9, 2021

Panama disease, Cavendish banana, Tropics, Fusarium wilt, TR4, Banana, Edible plants, Tropical agriculture, Banana production, Fusarium oxysporum f.sp. cubense, Taiwan Banana Research Institute

Fusarium wilt TR4 (previously referred to as the Panama Disease) is a devastating pathogen ravaging the $25 billion global banana industry .

Key Points:

Fusarium wilt TR4 (previously referred to as the Panama Disease) is a devastating pathogen ravaging the $25 billion global banana industry .
100% control was achieved at economic rates as low as 5 gal/acre (49 L/ha) within a 3 day testing period.
Additionally, MustGrow believes its work in Colombia will serve as a beachhead to expand into other leading banana producing countries.
Fusarium wilt TR4 is the world's most destructive banana disease, affecting particularly Cavendish bananas, which comprise half of global banana production.

MustGrow Confirms Proceeds of C$1.5 Million from Warrant Exercise

Retrieved on:

Thursday, January 14, 2021

Corporate finance, Equity securities, Options, Warrant, Fusarium wilt, TR4

The Company intends to use the proceeds of the warrant exercise to advance its organic mustard plant-based crop protection technologies and for general working capital purposes.

Key Points:

The Company intends to use the proceeds of the warrant exercise to advance its organic mustard plant-based crop protection technologies and for general working capital purposes.
"Our shareholders have demonstrated strong support through continued exercise of warrants which further bolsters our cash position to over C$3.1 million," commented MustGrow CEO Corey Giasson.
In addition, MustGrow has issued 100,000 common share purchase warrants (each a "Warrant") to a MustGrow advisor for continued work on MustGrow's Fusarium wilt TR4 trials in Colombia.
The Company has approximately 40.7 million basic common shares issued and outstanding and 50.6 million shares fully diluted.

DGAP-News: MustGrow Commences Banana Panama Disease Testing in Colombia

Retrieved on:

Tuesday, September 29, 2020

Tropical agriculture, Tropics, Cavendish banana, Panama disease, Fusarium wilt, Agriculture, TR4, Banana, Edible plants, Banana production, Taiwan Banana Research Institute, Fusarium oxysporum f.sp. cubense

Saskatoon, SK, September 29, 2020 - MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) (the "Company", "MustGrow") announces the commencement of testing of MustGrow's proprietary TerraMG bio-pesticide formulation on the Panama Disease (Fusarium wilt TR4), a devastating disease pathogen ravaging the $25 billion global banana industry .

Key Points:

Saskatoon, SK, September 29, 2020 - MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) (the "Company", "MustGrow") announces the commencement of testing of MustGrow's proprietary TerraMG bio-pesticide formulation on the Panama Disease (Fusarium wilt TR4), a devastating disease pathogen ravaging the $25 billion global banana industry .
The laboratory testing in Colombia will focus on the treatment of the Panama Disease.
Panama Disease is among the most destructive banana diseases, affecting particularly Cavendish bananas, which are half of all bananas produced globally.
Now, MustGrow is replicating this strategy in Colombia's besieged banana industry - focused on controlling and eliminating the Panama Disease.

Natural Fungicide and Bactericide Poised to Generate Global Revenue Stream & Save The Bananas

Retrieved on:

Friday, August 14, 2020

Branches of biology, Biocides, Fungicide, Mycology, Medical specialties, Biology, TR4, Plant pathology, Pathogen

Salveo's Tectus Matrix is a patent-pending, broad-spectrum natural and organic fungicide and bactericide liquid that controls and mitigates fungal and bacterial diseases in food, as well as ornamental crops and does not cause pathogenic mutations.

Key Points:

Salveo's Tectus Matrix is a patent-pending, broad-spectrum natural and organic fungicide and bactericide liquid that controls and mitigates fungal and bacterial diseases in food, as well as ornamental crops and does not cause pathogenic mutations.
The new TR4 strain also affects more varieties of bananas, many which are the primary food source in countries around the world.
Accordingto the Food and Agriculture Organization of the United Nations (FAO), TR4 is the most destructive of all banana plant diseases.
Salveo, Inc. a Florida Corporation (Salveo Naturals) founded in July 2016, USA was created to make natural fungicides and bactericides.

Dole Unveils Integrated Strategy Against Banana Disease

Retrieved on:

Friday, July 31, 2020

Retail, Agriculture, Natural Resources, Research, Science, Food, Beverage, Bananas, Agriculture in Honduras, Honduras Foundation for Agricultural Research, Agriculture, Banana production, Tropical fruit, Tropical agriculture, Dole Food Company, TR4, Biosecurity, Doles, Goldfinger banana

A three-year containment program was immediately implemented in 2019 to ensure biosecurity protocols in every Dole banana farm, as well as those of Doles independent suppliers.

Key Points:

A three-year containment program was immediately implemented in 2019 to ensure biosecurity protocols in every Dole banana farm, as well as those of Doles independent suppliers.
One such solution the company is investigating is how to implement safe and approved biological control measures to prevent disease.
Additionally, Dole is working closely with research institutions around the world toward developing a disease resistant banana variety through crop improvement and conventional breeding methods.
Since 2016, Dole has participated in a consortium working in partnership with the Honduran Research Foundation (FHIA) on the development of banana varieties that are resistant to TR4.

Rahan Meristem (1998) LTD and its Partner Banarica Report Success in Mitigating Panama Disease After Field Trials in the Philippines

Retrieved on:

Monday, July 20, 2020

Rahan Meristem, with the aid of our Colombian partner Mr. Luis Alberto Restrepo President of Banarica Colombia, developed Cavendish banana plants with apparent resistance to Panama disease TR4, reports the Scientific Director Dr. Eli Khayat.

Key Points:

Rahan Meristem, with the aid of our Colombian partner Mr. Luis Alberto Restrepo President of Banarica Colombia, developed Cavendish banana plants with apparent resistance to Panama disease TR4, reports the Scientific Director Dr. Eli Khayat.
These data corroborate the Companys earlier findings that its proprietary In-vitro mutagenesis technology is effective for creating novel traits.
In addition to these disease-resistance data, Rahan has previously shown both an increase in banana fruit production and improvement in plant architecture.
The data lead to the achievement of Rahan's R&D objective developing a "Cavendish" banana with resistance to fungal diseases.

MustGrow to Commence Work on Disease Threatening Global Banana Supply: Fusarium wilt Tropical Race 4

Retrieved on:

Tuesday, November 12, 2019

Fusarium wilt, Fusarium oxysporum, TR4, Fusarium, Fusarium oxysporum f.sp. betae, Panama disease

SASKATOON, Saskatchewan, Nov. 12, 2019 (GLOBE NEWSWIRE) -- MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based bio-pesticides, is pleased to announce its intent to address a new Fusarium pathogen known as Fusarium wilt Tropical Race 4 (Fusarium wilt TR4), a soil-borne disease pathogen plaguing the global banana supply.

Key Points:

SASKATOON, Saskatchewan, Nov. 12, 2019 (GLOBE NEWSWIRE) -- MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based bio-pesticides, is pleased to announce its intent to address a new Fusarium pathogen known as Fusarium wilt Tropical Race 4 (Fusarium wilt TR4), a soil-borne disease pathogen plaguing the global banana supply.
MustGrows previous independent efficacy studies involving the treatment of Fusarium oxysporum (Fusarium), a soil-borne pathogen potentially similar to Fusarium wilt TR4, have demonstrated 100% control of the fungus.
Its new race, Fusarium wilt TR4, has been causing serious banana losses in Southeast Asia, resulting in abandonment of thousands of hectares.
Fusarium wilt TR4 is among the most destructive diseases of bananas, affecting particularly Cavendish bananas, supplying around half of global banana production.